Atria Investments Inc Has $224,000 Position in Transcat, Inc. (NASDAQ:TRNS)

Atria Investments Inc cut its stake in shares of Transcat, Inc. (NASDAQ:TRNS) by 27.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,852 shares of the scientific and technical instruments company’s stock after selling 707 shares during the quarter. Atria Investments Inc’s holdings in Transcat were worth $224,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Quadrature Capital Ltd bought a new position in Transcat during the 1st quarter valued at about $619,000. Conestoga Capital Advisors LLC increased its holdings in shares of Transcat by 17.9% during the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock worth $109,561,000 after buying an additional 137,830 shares in the last quarter. Calamos Advisors LLC raised its stake in shares of Transcat by 76.0% in the second quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company’s stock valued at $1,848,000 after acquiring an additional 6,667 shares during the last quarter. First Horizon Advisors Inc. boosted its holdings in shares of Transcat by 26.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock worth $72,000 after acquiring an additional 125 shares in the last quarter. Finally, Raymond James & Associates grew its position in Transcat by 157.2% during the 3rd quarter. Raymond James & Associates now owns 20,651 shares of the scientific and technical instruments company’s stock worth $2,494,000 after acquiring an additional 12,622 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Analysts Set New Price Targets

TRNS has been the subject of a number of recent analyst reports. Oppenheimer reaffirmed an “outperform” rating and set a $130.00 price target (down from $155.00) on shares of Transcat in a report on Wednesday, October 30th. Craig Hallum lowered their target price on Transcat from $138.00 to $113.00 and set a “buy” rating for the company in a research note on Wednesday, October 30th. HC Wainwright reaffirmed a “buy” rating and issued a $156.00 price target on shares of Transcat in a report on Tuesday, October 29th. Northland Securities decreased their price objective on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a report on Wednesday, October 30th. Finally, StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $127.25.

Transcat Stock Up 2.1 %

TRNS stock opened at $109.02 on Friday. Transcat, Inc. has a twelve month low of $94.29 and a twelve month high of $147.12. The company has a market cap of $1.00 billion, a P/E ratio of 55.06 and a beta of 0.69. The business has a fifty day moving average of $116.61 and a 200-day moving average of $121.50.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a return on equity of 7.36% and a net margin of 6.63%. The firm had revenue of $67.83 million for the quarter, compared to the consensus estimate of $70.30 million. During the same period in the prior year, the firm posted $0.41 earnings per share. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Transcat, Inc. will post 1.76 earnings per share for the current fiscal year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.